Demethoxycurcumin inhibits cell proliferation, migration and invasion in prostate cancer cells

Oncology Reports

Volumn 28, Issue 1, 2012, Pages 85-90

  Ni, Xiaochen ^a   Zhang, Aili ^a   Zhao, Zhihong ^a   Shen, Yongqing ^a   Wang, Shijie ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Curcumin; Curcuminoids; Demethoxycurcumin; Migration; Proliferation; Prostate cancer

Indexed keywords

CASPASE 3; DEMETHOXYCURCUMIN; DIMETHYL SULFOXIDE; GELATINASE A;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG DETERMINATION; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CURCUMIN; ENZYME ACTIVATION; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; MALE; MATRIX METALLOPROTEINASE 2; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84861555754     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1783     Document Type: Article

References (30)

1. McCann SE, Ambrosone CB, Moysich KB, Brasure J, Marshall JR, Freudenheim JL, Wilkinson GS and Graham S: Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 53: 33-41, 2005 (Pubitemid 43068551)
2. Teiten MH, Gaascht F, Cronauer M, Henry E, Dicato M and Diederich M: Anti-proliferative potential of curcumin in androgendependent prostate cancer cells occurs through modulation of the Wingless signaling pathway. Int J Oncol 38: 603-611, 2011.
3. Dorai T, Gehani N and Katz A: Therapeutic potential of curcumin in human prostate cancer - I. Curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells. Prostate Cancer Prostatic Dis 3: 84-93, 2000. (Pubitemid 30665213)
4. Deeb D, Xu YX, Jiang H, Gao X, Janakiraman N, Chapman RA and Gautam SC: Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. Mol Cancer Ther 2: 95-103, 2003.
5. Mehta K, Pantazis P, McQueen T and Aggarwal BB: Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 8: 470-481, 1997. (Pubitemid 27310917)
6. Lee YK, Park SY, Kim YM and Park OJ: Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Ann NY Acad Sci 1171: 489-494, 2009.
7. Ireson C, Orr S, Jones DJ, Verschoyle R, Lim CK, Luo JL, Howells L, Plummer S, Jukes R, Williams M, Steward WP and Gescher A: Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 61: 1058-1064, 2001. (Pubitemid 32174425)
8. Ireson CR, Jones DJ, Orr S, Coughtrie MW, Boocock DJ, Williams ML, Farmer PB, Steward WP and Gescher AJ: Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11: 105-111, 2002. (Pubitemid 34118319)
9. Han G, Cui JJ, Bi R, Zhao LL and Zhang WG: Study on stability of curcumine, demethoxycurcumin and bisdemethoxycurcumin. Zhongguo Zhong Yao Za Zhi 33: 2611-2614, 2008 (In Chinese).
10. Tamvakopoulos C, Dimas K, Sofianos ZD, Hatziantoniou S, Han Z, Liu ZL, Wyche JH and Pantazis P: Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin. Clin Cancer Res 13: 1269-1277, 2007. (Pubitemid 46424068)
11. Lee JW, Hong HM, Kwon DD, Pae HO and Jeong HJ: Dimethoxycurcumin, a structural analogue of curcumin, induces apoptosis in human renal carcinoma caki cells through the production of reactive oxygen species, the release of cytochrome C, and the activation of caspase-3. Korean J Urol 51: 870-878, 2010.
12. Yodkeeree S, Ampasavate C, Sung B, Aggarwal BB and Limtrakul P: Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line. Eur J Pharmacol 627: 8-15, 2010.
13. Luthra PM, Kumar R and Prakash A: Demethoxycurcumin induces Bcl-2 mediated G2/M arrest and apoptosis in human glioma U87 cells. Biochem Biophys Res Commun 384: 420-425, 2009.
14. Thayyullathil F, Chathoth S, Hago A, Patel M and Galadari S: Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and -independent apoptosis in L929 cells. Free Radic Biol Med 45: 1403-1412, 2008.
15. 2+ and the activation of caspase-3. Anticancer Res 26: 4379-4389, 2006.
16. Stearns M and Stearns ME: Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression. Oncol Res 8: 69-75, 1996. (Pubitemid 26134926)
17. Stearns ME and Stearns M: Immunohistochemical studies of activated matrix metalloproteinase-2 (MMP-2a)expression in human prostate cancer. Oncol Res 8: 63-67, 1996.
18. Montironi R, Lucarini G, Castaldini C, Galluzzi CM, Biagini G and Fabris G: Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia. Anticancer Res 16: 2057-2062, 1996. (Pubitemid 26270724)
19. Simon A, Allais DP, Duroux JL, Basly JP, Durand-Fontanier S and Delage C: Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Lett 129: 111-116, 1998. (Pubitemid 28375245)
20. Yodkeeree S, Chaiwangyen W, Garbisa S and Limtrakul P: Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J Nutr Biochem 20: 87-95, 2009.
21. Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL, Lin JP, Ma YS, Wu CC and Chung JG: Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor (VEGF). Cancer Lett 285: 127-133, 2009.
22. Chen HW, Lee JY, Huang JY, Wang CC, Chen WJ, Su SF, Huang CW, Ho CC, Chen JJ, Tsai MF, Yu SL and Yang PC: Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 68: 7428-7438, 2008.
23. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM and Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284: 67-68, 1980. (Pubitemid 10098769)
24. Kawano N, Osawa H, Ito T, Nagashima Y, Hirahara F, Inayama Y, Nakatani Y, Kimura S, Kitajima H, Koshikawa N, Miyazaki K and Kitamura H: Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study. Hum Pathol 28: 613-622, 1997. (Pubitemid 27213059)
25. Fishman DA, Bafetti LM and Stack MS: Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells. Invasion Metastasis 16: 150-159, 1996. (Pubitemid 27239186)
26. Young TN, Rodriguez GC, Rinehart AR, Bast RC Jr, Pizzo SV and Stack MS: Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2. Gynecol Oncol 62: 89-99, 1996.
27. Bramhall SR, Neoptolemos JP, Stamp GW and Lemoine NR: Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J Pathol 182: 347-355, 1997. (Pubitemid 27285789)
28. Murray GI, Duncan ME, O'Neil P, McKay JA, Melvin WT and Fothergill JE: Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 185: 256-261, 1998. (Pubitemid 28320046)
29. Murray GI, Duncan ME, O'Neil P, Melvin WT and Fothergill JE: Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 2: 461-462, 1996. (Pubitemid 26191919)
30. Kaighn GI, Narayan KS, Ohnuki Y, Lechner JF and Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23, 1979. (Pubitemid 9239413)